Spark Therapeutics, Inc. - FORM S-1 - EX-23.1

file	filename
S-1 - FORM S-1 - Spark Therapeutics, Inc.	d776249ds1.htm
EX-10.21 - EX-10.21 - Spark Therapeutics, Inc.	d776249dex1021.htm
EX-10.1 - EX-10.1 - Spark Therapeutics, Inc.	d776249dex101.htm
EX-10.13 - EX-10.13 - Spark Therapeutics, Inc.	d776249dex1013.htm
EX-4.2 - EX-4.2 - Spark Therapeutics, Inc.	d776249dex42.htm
EX-10.8 - EX-10.8 - Spark Therapeutics, Inc.	d776249dex108.htm
EX-10.16 - EX-10.16 - Spark Therapeutics, Inc.	d776249dex1016.htm
EX-3.4 - EX-3.4 - Spark Therapeutics, Inc.	d776249dex34.htm
EX-3.1 - EX-3.1 - Spark Therapeutics, Inc.	d776249dex31.htm
EX-10.17 - EX-10.17 - Spark Therapeutics, Inc.	d776249dex1017.htm
EX-10.18 - EX-10.18 - Spark Therapeutics, Inc.	d776249dex1018.htm
EX-10.4 - EX-10.4 - Spark Therapeutics, Inc.	d776249dex104.htm
EX-10.19 - EX-10.19 - Spark Therapeutics, Inc.	d776249dex1019.htm
EX-10.3 - EX-10.3 - Spark Therapeutics, Inc.	d776249dex103.htm
EX-10.9 - EX-10.9 - Spark Therapeutics, Inc.	d776249dex109.htm
EX-10.12 - EX-10.12 - Spark Therapeutics, Inc.	d776249dex1012.htm
EX-10.10 - EX-10.10 - Spark Therapeutics, Inc.	d776249dex1010.htm
EX-3.2 - EX-3.2 - Spark Therapeutics, Inc.	d776249dex32.htm
EX-10.11 - EX-10.11 - Spark Therapeutics, Inc.	d776249dex1011.htm
EX-10.15 - EX-10.15 - Spark Therapeutics, Inc.	d776249dex1015.htm
EX-10.14 - EX-10.14 - Spark Therapeutics, Inc.	d776249dex1014.htm
EX-10.2 - EX-10.2 - Spark Therapeutics, Inc.	d776249dex102.htm
EX-3.3 - EX-3.3 - Spark Therapeutics, Inc.	d776249dex33.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Spark Therapeutics, Inc.:

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

Philadelphia, Pennsylvania

December 30, 2014

Spark Therapeutics, Inc. - FORM S-1 - EX-23.1 - December 30, 2014